Rebecca Taub

2019

In 2019, Rebecca Taub earned a total compensation of $5.3M as President, Research & Development and Chief Medical Officer, at Synta Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$274,775
Option Awards$4,531,120
Salary$463,948
Total$5,269,843

Taub received $4.5M in option awards, accounting for 86% of the total pay in 2019.

Taub also received $274.8K in non-equity incentive plan and $463.9K in salary.

Rankings

In 2019, Rebecca Taub's compensation ranked 2,049th out of 13,971 executives tracked by ExecPay. In other words, Taub earned more than 85.3% of executives.

ClassificationRankingPercentile
All
2,049
out of 13,971
85th
Division
Manufacturing
745
out of 5,701
87th
Major group
Chemicals And Allied Products
225
out of 2,200
90th
Industry group
Drugs
182
out of 1,886
90th
Industry
Pharmaceutical Preparations
132
out of 1,398
91st

Pay ratio

Rebecca Taub's Pay$5,269,843
Median Employee's Pay$791,000
Pay Ratio

7

to 1

In 2019, the annual total compensation of Rebecca Taub was $5,269,843.

The annual total compensation of the median employee at Synta Pharmaceuticals was $791,000.

The ratio of Rebecca Taub's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 29, 2020.

Taub's colleagues

We found four more compensation records of executives who worked with Rebecca Taub at Synta Pharmaceuticals in 2019.

2019

Paul Friedman

Synta Pharmaceuticals

Chief Executive Officer

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

2019

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like